This pathway is to be used for oncology patients with a new diagnosis/new relapse of a hematological malignancy or bulky solid tumor with presence of high risk criteria.

This pathway provides guidance for the care of patients at baseline risk for malnutrition and/or unlikely to consume adequate caloric intake by mouth within 3 days of admission to the ICU.

This pathway should be used to guide the management of infants requiring a Partial Volume Exchange Transfusion (PVET). Most common reasons for PVET include severe chronic anemia or Polycythemia/Hyperviscosity syndrome.

Ankyloglossia (Tongue-Tie), Outpatient Specialty Care, Primary Care

This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.

This pathway should be used to guide the screening, assessment, and care planning for patients at risk for anxiety or obsessive- compulsive disorder in the outpatient setting.

This pathway will guide the evaluation and treatment of a pediatric patient with a suspected acute pulmonary embolism/embolus.

The developmental delay/intellectual disability clinical pathway guide the evaluation of children with suspected developmental delay or intellectual disability in primary care setting. 

This clinical pathway details the steps in identifying and managing children and adolescents who ingest toxic substances. It should be used in all cases of ingestion regardless of the child’s or adolescent’s intention.

The post – N/IICU patient with severe Bronchopulmonary Dysplasia (BPD) clinical pathway will guide transfer from N/IICU to complex care service, weaning of respiratory support, and discharge planning.